Basics Curis, Inc. Curis Inc is a biotechnology company engaged in developing and commercializing drug candidates for the treatment of human cancers. Its pipeline products include CUDC-907, CA-170, CA-4948, CA-327, and Erivedge. IPO Date: August 1, 2000 Sector: Healthcare Industry: Biotech Market Cap: $17.45M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 3.59% Avg Daily Range (30 D): $0.06 | 4.89% Avg Daily Range (90 D): $0.05 | 3.57% Institutional Daily Volume Avg Daily Volume: .64M Avg Daily Volume (30 D): .08M Avg Daily Volume (90 D): .06M Trade Size Avg Trade Size (Sh.): 251 Avg Trade Size (Sh.) (30 D): 234 Avg Trade Size (Sh.) (90 D): 189 Institutional Trades Total Inst.Trades: 619 Avg Inst. Trade: $1.7M Avg Inst. Trade (30 D): $1.07M Avg Inst. Trade (90 D): $1.07M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.22M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 16.83K     News Aug 5, 2025 @ 10:10 PM Curis (CRIS) Q2 Loss Narrows 66% Source: Jesterai Jul 11, 2024 @ 10:09 AM VISTA Inhibitor Clinical Trials Drug Approval Insi... Source: Kuick Research Apr 12, 2024 @ 12:34 PM Top 3 Health Care Stocks That May Collapse In Q2 Source: Avi Kapoor Apr 5, 2024 @ 12:43 PM Strength Seen in Curis (CRIS): Can Its 19.5% Jump ... Source: Zacks Equity Research Feb 9, 2024 @ 1:11 PM CyberArk Software To Rally Around 19%? Here Are 10... Source: Avi Kapoor Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.3 $-.49 $-.68 Diluted EPS $-3.3 $-.49 $-.68 Revenue $ 11.65M $ 3.18M $ 2.75M Gross Profit $ $ $ Net Income / Loss $ -36.56M $ -7.73M $ -8.59M Operating Income / Loss $ -34.33M $ -6.92M $ -8.25M Cost of Revenue $ $ $ Net Cash Flow $ -.86M $ M $ M PE Ratio     Splits Sep 29, 2023:   1:20 May 30, 2018:   1:5